SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Pharmaceuticals informs about board meeting

29 Oct 2021 Evaluate

Suven Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 06/11/2021 to consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the second quarter and half-year ending September 30, 2021 and related matters. Trading Window for dealing in the securities of the company is already closed from 01st October, 2021 as per PIT Code of the Company. Trading window will be opened from 10th November, 2021.

The above information is a part of company’s filings submitted to BSE.

Cohance Lifesciences Share Price

369.35 -22.25 (-5.68%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×